Loading
Latest filing published 22 Dec 2025 for CITIUS ONCOLOGY, INC..
No signal scores available.
Myron Czuczman is a declared insider of Citius Oncology, Inc., with filings sourced from SEC (Form 4). We count 3 filings, every one of them for a trade on 19 September 2025.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 22 December 2025 came the latest disclosure, a share grant in Citius Oncology, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations